For its work and commitment in various areas of research, the Neolpharma Group has been recognized by various institutions, among others, CONACYT who granted Neolpharma its Culture and Technological Innovation award (RENIECYT) for its commitment to research and development.
One of the researches by the Neolpharma Group was granted the CANIFARMA 2012 Award, which recognizes the talent and effort of Mexico's scientific community in the field of Clinical Research by testing and proving the efficacy and safety of an innovative development in epileptic patients.